The Ministry of Health of the Republic of Mauritius has approved the use of Sputnik Light, a single-dose vaccine against coronavirus, the Russian Direct Investment Fund (RDIF) said in a press release on Wednesday.
The Ministry of Health and Wellness of the Republic of Mauritius has approved the Russian single-dose Sputnik Light vaccination against coronavirus, according to the Russian Direct Investment Fund.
According to the press release, the Mauritius Ministry of Health authorized the two-dose Sputnik V vaccine for use under the emergency use permission procedure in March 2021, TASS reports.
Sputnik Light (recombinant human adenovirus serotype number 26 (rAd26)) is the initial component of Sputnik V. According to data evaluated from 28 days following the injection, Sputnik Light was shown to be 79.4 percent effective.
The information was gathered from Russians who were vaccinated with a single shot and did not receive a second for any reason between December 5, 2020, and April 15, 2021, as part of a mass vaccination campaign. According to RDIF, the vaccine’s effectiveness is approximately 80 percent, which is greater than many two-dose immunizations.
Sputnik V has been approved in 66 countries with a combined population of more than 3.2 billion people.